What Happened?
Rockville, -based Ascentage-Pharma Promoted Thomas Knapp as Senior Vice President and General Counsel
About the Company
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company`s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors.
About the Person
Thomas Knapp is Senior Vice President of Legal Affairs at Ascentage Pharma. Previously, Thomas held various senior legal leadership roles in the industry.
Info Source
News
Short Profile